Invasive Breast Cancer
📧 Sign up to get email alerts when something new happens for Invasive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer [Phase 2]
Phase 2 neoadjuvant endocrine therapy trial in hormone receptor-positive, HER2-negative, node-negative breast cancer completed. Results post…
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors [Phase 2]
Phase 2 trial evaluating docosahexaenoic acid (DHA) in breast cancer survivors has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer [Phase 2]
A Phase 2 clinical trial comparing hypofractionated radiation therapy to standard radiation therapy for ductal carcinoma in situ or early in…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer [Phase 2]
Phase 2 clinical trial investigating naltrexone for treatment-emergent fatigue in patients receiving radiation therapy for breast cancer; st…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer [Phase 2]
Phase 2 trial investigating vandetanib's effect on cellular markers in invasive breast cancer; study terminated with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Pre-Surgical Intervention for Targeted Therapies for Breast Cancer [NA]
Clinical trial update on pre-surgical intervention using targeted therapies for invasive breast cancer; study completed with posted results.
-
FDA approval · 2020-08-18FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved Modavar Pharmaceuticals' original application for raloxifene hydrochloride, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2019-10-03Clinical Trial Update: Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation [Phase 3]
Phase 3 trial comparing mometasone furoate 0.1% to Eucerin for skin toxicities in breast cancer patients receiving postmastectomy radiation;…
-
FDA approval · 2019-08-23FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals' supplemental application for raloxifene hydrochloride (generic). The drug is indicated for postmenopa…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.
This clinical trial update reports on a completed study comparing core needle biopsy and surgical specimens for ER, PgR, HER2, and Ki-67 sta…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating MK-2206 in combination with anastrozole and/or fulvestrant in postmenopausal women with metastatic breast cancer; s…
-
CLINICAL_TRIALS research · 2018-06-25Clinical Trial Update: Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy [Phase 2, Phase 3]
Trial update on using prophylactic gabapentin to prevent taxane-induced arthralgia and myalgia in breast cancer patients receiving adjuvant …
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy [NA]
Clinical trial update for proton radiation therapy after mastectomy in invasive breast cancer; status and results not clearly reported.
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: A Prototype Tri-modal Imaging Device for Breast Cancer [Phase 1]
A Phase 1 trial evaluating a prototype tri-modal imaging device for breast cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2017-12-05Clinical Trial Update: MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating MRI to predict tumor response after radiofrequency ablation in women with invasive breast cancer has bee…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: X-Ray Mammography Standard of Care Protocol
The NIH Clinical Center conducted and completed a trial on an X-ray mammography standard-of-care protocol (NCT01052740). The trial covered v…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery [Phase 2]
A Phase 2 trial evaluating radiation therapy in postmenopausal women with early-stage breast cancer undergoing surgery was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. [Phase 2]
Phase 2 trial evaluating anti-hormone therapy combining anastrazole and fulvestrant before surgery in postmenopausal women with invasive bre…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: AKT Inhibitor in Oestrogen Positive Breast Cancer [Phase 2]
A Phase 2 clinical trial of an AKT inhibitor for estrogen receptor-positive breast cancer has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging
A completed clinical trial comparing digital breast tomosynthesis versus contrast-enhanced MRI for breast cancer staging.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic Therapy
The Symphony Triple A Study evaluating the Symphony gene expression–based tool to guide adjuvant systemic therapy decisions in breast cancer…
-
CLINICAL_TRIALS research · 2016-11-18Clinical Trial Update: A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer [Phase 2]
Clinical trial update for a Phase 2 randomized, double-blind study of chloroquine in breast cancer (invasive) with unknown status.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM" [NA]
This clinical trial update reports the re-evaluation of tumor samples from women with invasive breast cancer using the MammaTyper diagnostic…
-
FDA approval · 2016-10-12FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approves the original application for raloxifene hydrochloride from ScieGen Pharmaceuticals Inc, providing a generic option for postmeno…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer [Phase 3]
Phase 3 trial evaluating AC chemotherapy followed by paclitaxel plus trastuzumab and/or lapatinib given before surgery in operable HER2-posi…